The 5th Cancer Targets & Therapeutics Conference, taking place on July 7-8, 2014 in Boston, MA

From Kristen Starkey
March 29, 2014 - 10:32am

With the rapid progression of molecular biology and genetics, and the subsequent emergence of many new targets, emerging targets and therapeutics provide new opportunities for the prevention and treatment of several major disease systems. The 5th Cancer Targets & Therapeutics Conference, taking place on July 7-8, 2014 in Boston, MA will continue to be a premier event for translational researchers, preclinical scientists and managers, and those carrying out early phase clinical trials, working to identify and exploit advances in the field in order to deliver products with a meaningful clinical impact. Both cutting-edge researchers and those who guide its commercial development will be on-hand to share their knowledge and insights as to how therapeutic cancer targets are identified, and how this research translates into meaningful therapeutics that benefit patients living with cancer.2014 Session Topics:I. Bridging Genomics & Proteomics in CancerII. Cancer Biomarkers in Discovery & Clinical Trials III. Emerging Cancer Targets & Therapeutic Strategies         - Kinse Inhibitors          - Epigenetic Regulators          - Metabolic Pathways          - Cancer Stem Cells IV. Progress in Cancer ImmunotherapyV. Combination Strategies in Immuno-Oncology VI. Clinical Drug Development This conference is part of our larger Novel Cancer Therapeutics Summit 2014, which includes one additional parallel conference: Novel Cancer Therapeutics Summit 2014:2nd Oncology Partnering & Deal-Making4th Cancer Targets & Therapeutics

We invite you to attend the 6th Non-Coding RNA & RNAi Therapeutics Conference, which will take place September 9-10, 2015 in Philadelphia, PA. The conference will bring together an exciting balance of industry and academia, so that delegates have the unique opportunity to network with colleagues in the RNA research field. Emerging areas in RNA research provide great insight into promising therapeutic tools. Delivery has remained a solid focus for understanding how RNA has proven to play a vital and central role in all cellular function. The excitement and interest that CRISPR brings continues to progress the evolution of genome editing tools. We will also dive into application of aptamers in diagnostic and therapeutic settings.

Kristen Starkey's website »